MedTrace Logo

SAFE Study - Septal Pacing for Atrial Fibrillation Suppression Evaluation

NCT00419640 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 385

Last updated 2019-02-04

No results posted yet for this study

Summary

This is a randomized, parallel, single-blinded multi-center study. The objective is to compare the long term clinical outcomes among the site of atrial pacing and to compare the long term effect of the atrial fibrillation (AF) Suppression algorithm.

Conditions

Interventions

DEVICE

Pacemaker implantation with RA lead in LAS position

Pacemaker implantation with RA lead placed in low atrial septal position

DEVICE

Pacemaker implantation with RA lead in LAS position

Pacemaker implantation with RA lead placed in low atrial septal position

DEVICE

Pacemaker implantation with RA lead in RAA position

Pacemaker implantation with RA lead placed in right atrial appendage position

DEVICE

Pacemaker implantation with RA lead in RAA position

Pacemaker implantation with RA lead placed in right atrial appendage position

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Chu-Pak Lau, Prof. · The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2012-02-29
Completion
2012-11-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00419640 on ClinicalTrials.gov